Ocuphire Pharma Inc
General ticker "OCUP" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $29.8M
Ocuphire Pharma Inc does not follow the US Stock Market performance with the rate: -32.6%.
Estimated limits based on current volatility of 6.4%: low 0.88$, high 1.00$
Factors to consider:
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.56$, 3.91$]
- 2024-12-30 to 2025-12-30 estimated range: [1.51$, 3.73$]
Financial Metrics affecting the OCUP estimates:
- Negative: Non-GAAP EPS, $ of -0.48 <= 0.10
- Negative: Operating profit margin, % of -35.67 <= 1.03
- Negative: Operating cash flow per share per price, % of -1.84 <= 2.35
- Negative: negative Net income
Short-term OCUP quotes
Long-term OCUP plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.59MM | $39.85MM | $19.05MM |
| Operating Expenses | $23.29MM | $21.62MM | $29.61MM |
| Operating Income | $-22.70MM | $18.23MM | $-10.56MM |
| Non-Operating Income | $-33.99MM | $-0.02MM | $0.59MM |
| Interest Expense | $0.00MM | $0.01MM | $0.00MM |
| R&D Expense | $15.17MM | $14.36MM | $17.65MM |
| Income(Loss) | $-56.69MM | $18.20MM | $-9.97MM |
| Taxes | $0.00MM | $0.32MM | $0.01MM |
| Profit(Loss) | $-56.69MM | $17.89MM | $-9.99MM |
| Stockholders Equity | $22.22MM | $46.24MM | $49.91MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $26.08MM | $48.99MM | $53.95MM |
| Operating Cash Flow | $-19.37MM | $14.31MM | $-1.11MM |
| Investing Cash Flow | $-0.10MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $27.61MM | $3.79MM | $8.98MM |
| Earnings Per Share* | $-3.81 | $0.90 | $-0.46 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.